Leighton JA - Search Results

1

Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.

Afif W, Leighton JA, Hanauer SB, Loftus EV Jr, Faubion WA, Pardi DS, Tremaine WJ, Kane SV, Bruining DH, Cohen RD, Rubin DT, Hanson KA, Sandborn WJ. Afif W, et al. Among authors: leighton ja. Inflamm Bowel Dis. 2009 Sep;15(9):1302-7. doi: 10.1002/ibd.20924. Inflamm Bowel Dis. 2009. PMID: 19408340 Clinical Trial.

2

Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study.

Sandborn WJ, Tremaine WJ, Leighton JA, Lawson GM, Zins BJ, Compton RF, Mays DC, Lipsky JJ, Batts KP, Offord KP, Hurt RD, Green J. Sandborn WJ, et al. Among authors: leighton ja. Aliment Pharmacol Ther. 1997 Aug;11(4):663-71. doi: 10.1046/j.1365-2036.1997.00208.x. Aliment Pharmacol Ther. 1997. PMID: 9305473 Free article. Clinical Trial.

3

A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis.

Egan LJ, Sandborn WJ, Tremaine WJ, Leighton JA, Mays DC, Pike MG, Zinsmeister AR, Lipsky JJ. Egan LJ, et al. Among authors: leighton ja. Aliment Pharmacol Ther. 1999 Dec;13(12):1597-604. doi: 10.1046/j.1365-2036.1999.00667.x. Aliment Pharmacol Ther. 1999. PMID: 10594394 Free article. Clinical Trial.

4

Re: Kreiss et al.: Pneumatosis intestinalis complicating C. difficile pseudomembranous colitis.

Pardi DS, Leighton JA. Pardi DS, et al. Among authors: leighton ja. Am J Gastroenterol. 2000 Apr;95(4):1107. doi: 10.1111/j.1572-0241.2000.01967.x. Am J Gastroenterol. 2000. PMID: 10763988 No abstract available.

5

Cyclosporine, or cyclosporine not, for severe ulcerative colitis.

Leighton JA. Leighton JA. Inflamm Bowel Dis. 2001 Nov;7(4):350-2. doi: 10.1097/00054725-200111000-00017. Inflamm Bowel Dis. 2001. PMID: 11720331 No abstract available.

6

The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease.

Meyer AM, Ramzan NN, Loftus EV Jr, Heigh RI, Leighton JA. Meyer AM, et al. Among authors: leighton ja. J Clin Gastroenterol. 2004 Oct;38(9):772-5. doi: 10.1097/01.mcg.0000139057.05297.d6. J Clin Gastroenterol. 2004. PMID: 15365403

7

Evolving diagnostic modalities in inflammatory bowel disease.

Leighton JA, Loftus EV Jr. Leighton JA, et al. Curr Gastroenterol Rep. 2005 Dec;7(6):467-74. doi: 10.1007/s11894-005-0078-x. Curr Gastroenterol Rep. 2005. PMID: 16313877 Review.

8

Role of capsule endoscopy in inflammatory bowel disease: where we are and where we are going.

Leighton JA, Legnani P, Seidman EG. Leighton JA, et al. Inflamm Bowel Dis. 2007 Mar;13(3):331-7. doi: 10.1002/ibd.20058. Inflamm Bowel Dis. 2007. PMID: 17206673 Review.

9

Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.

Sandborn WJ, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S. Sandborn WJ, et al. Among authors: leighton ja. Gastroenterology. 2010 Apr;138(4):1286-96, 1296.e1-3. doi: 10.1053/j.gastro.2009.12.054. Epub 2010 Jan 11. Gastroenterology. 2010. PMID: 20064514 Clinical Trial.

10

Quality commitment: the newly established American College of Gastroenterology Quality Council to meet the needs of clinical gastroenterology.

Kane S, Leighton J, Kefalas C, Cohen L, Katz P, Rizk M, Pike I, Lashner B, Ho I, Pochapin M, Seabrook M, Greenwald D, Demarco D, Johnson D. Kane S, et al. Am J Gastroenterol. 2013 Jan;108(1):7-9. doi: 10.1038/ajg.2012.319. Am J Gastroenterol. 2013. PMID: 23287937 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page